Introduction: The ACO Registry Study was a multicenter, prospective, observational cohort study aiming to clarify the situation of asthma-chronic obstructive pulmonary disease (COPD) overlap (ACO) within the COPD population using the Japanese Respiratory Society (JRS) criteria. We reported the proportion of patients who met the ACO criteria among the COPD population at study registration.

Methods: Using data collected at registration, we investigated the implementation of each diagnostic examination/test required for ACO diagnosis in the full analysis set. Among patients with data necessary for ACO diagnosis, ACO/non-ACO patients with/without asthma diagnosed by a physician and proportions of inhaled corticosteroid (ICS) treatments for COPD were calculated.

Results: Of 708 patients analyzed, 396 (55.9%) had the data necessary for ACO diagnosis, and 312 (44.1%) did not. The proportions of patients who underwent laboratory and respiratory function tests (peripheral blood eosinophil count [79.8%], fractional exhaled nitric oxide [63.7%], airway reversibility [46.8%], and total immunoglobulin [Ig] E/specific IgE [33.3%]) were lower than those who underwent subjective examinations (perennial allergic rhinitis [100%], asthma before age 40 years [97.2%], and variable/paroxysmal respiratory symptoms [94.5%]). Among patients with the data necessary for ACO diagnosis and without asthma complications according to the physician's diagnosis, 15.1% (33/219) met the ACO criteria. Of patients who met the ACO criteria, 74.3% (75/101) received ICS, and 25.7% (26/101) did not. By comparison, among patients who did not meet the ACO criteria, 35.6% (105/295) were receiving ICS, and 64.4% (190/295) were not.

Conclusions: The proportion of objective laboratory and physiological tests was lower than expected, despite study sites having the clinical resources for objective tests. Most ACO patients were being treated with ICS as recommended in the JRS treatment guidelines. Attempts should be made to further increase the proper use of ICS among these patients in Japan.

Trial Registration: ClinicalTrials.gov, NCT03577795.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464737PMC
http://dx.doi.org/10.1007/s12325-022-02167-5DOI Listing

Publication Analysis

Top Keywords

aco criteria
16
aco diagnosis
16
met aco
12
data aco
12
aco
11
patients
10
obstructive pulmonary
8
pulmonary disease
8
copd population
8
patients met
8

Similar Publications

Background: Despite the relatively small number of items on the Perceived Social Support Scale (PSSS-12), there has been a trend toward simplification of the scale in order to minimize testing time. In this situation, some researchers based on the responses of military spouses in the U.S.

View Article and Find Full Text PDF

Fatty acid (FA), tocopherol, and phytosterol profiles are used in avocado oil purity standards. However, blends with other oils can mimic the profile of pure avocado oil, resulting in similar ranges for these molecules. Therefore, fatty alcohol esters (FAEs) uniquely of spp.

View Article and Find Full Text PDF
Article Synopsis
  • * This study included 127 severe asthma patients to assess ACO prevalence using specific criteria, comparing outcomes between those with and without ACO.
  • * ACO was found in 31.5% of severe asthma patients, but it did not significantly impact the rates of exacerbations or the annual decline in lung function over the study period.
View Article and Find Full Text PDF

To ensure operational efficiency, promote sustainable wastewater treatment practices, and maintain compliance with environmental regulations, it is crucial to evaluate the parameters of treated effluent in wastewater treatment plants (WWTPs). Artificial neural network (ANN) analysis is a promising tool to predict the wastewater characteristics, as a substitute to tedious laboratory techniques. It enables proactive decision-making and contributes to the overall effectiveness of the treatment processes.

View Article and Find Full Text PDF

Distinct physiological, transcriptomic, and imaging characteristics of asthma-COPD overlap compared to asthma and COPD in smokers.

EBioMedicine

December 2024

Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA; Department of Medicine, Harvard Medical School, Boston, MA, 02115, USA.

Background: The clinical and pathological features of asthma and chronic obstructive pulmonary disease (COPD) can converge in smokers and elderly individuals as asthma-COPD overlap (ACO). This overlap challenges the diagnosis and treatment of the distinct aetiologies underlying these conditions.

Methods: We analysed 2453 smokers (≥10 pack-years), aged 45-80 years, from the Genetic Epidemiology of COPD (COPDGene) Study, stratified as Control, Asthma, COPD, and ACO based on Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!